J0891 — Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
J0891 is a HCPCS Level II code for injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use). It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J0891
- Long descriptor
- Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- Short descriptor
- Argatroban nonesrd (accord)
- Added
- January 1, 2023
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0891
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0891 is not quite right, the correct code is very often within a few positions of it.
- J0883Injection, argatroban, 1 mg (for non-esrd use)
- J0884Injection, argatroban, 1 mg (for esrd on dialysis)
- J0885Injection, epoetin alfa, (for non-esrd use), 1000 units
- J0886Injection, epoetin alfa, 1000 units (for esrd on dialysis)terminated
- J0887Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
- J0888Injection, epoetin beta, 1 microgram, (for non esrd use)
- J0889Daprodustat, oral, 1 mg, (for esrd on dialysis)terminated
- J0890Injection, peginesatide, 0.1 mg (for esrd on dialysis)
- J0892Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0893Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
- J0894Injection, decitabine, 1 mg
- J0895Injection, deferoxamine mesylate, 500 mg
- J0896Injection, luspatercept-aamt, 0.25 mg
- J0897Injection, denosumab, 1 mg
- J0898Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0899Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
Questions about J0891
What is HCPCS code J0891?
J0891 is a HCPCS Level II code for injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use). It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0891?
The CMS HCPCS file marks J0891 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
How is J0891 paid under the physician fee schedule?
J0891 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).